1. Home
  2. FGEN vs BWEN Comparison

FGEN vs BWEN Comparison

Compare FGEN & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • BWEN
  • Stock Information
  • Founded
  • FGEN 1993
  • BWEN N/A
  • Country
  • FGEN United States
  • BWEN United States
  • Employees
  • FGEN N/A
  • BWEN N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • FGEN Health Care
  • BWEN Industrials
  • Exchange
  • FGEN Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • FGEN 45.1M
  • BWEN 49.1M
  • IPO Year
  • FGEN 2014
  • BWEN N/A
  • Fundamental
  • Price
  • FGEN $11.12
  • BWEN $2.34
  • Analyst Decision
  • FGEN Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • FGEN 2
  • BWEN 1
  • Target Price
  • FGEN $146.50
  • BWEN $6.00
  • AVG Volume (30 Days)
  • FGEN 24.8K
  • BWEN 303.9K
  • Earning Date
  • FGEN 11-03-2025
  • BWEN 11-13-2025
  • Dividend Yield
  • FGEN N/A
  • BWEN N/A
  • EPS Growth
  • FGEN N/A
  • BWEN N/A
  • EPS
  • FGEN N/A
  • BWEN N/A
  • Revenue
  • FGEN $7,346,000.00
  • BWEN $145,141,000.00
  • Revenue This Year
  • FGEN N/A
  • BWEN $8.75
  • Revenue Next Year
  • FGEN N/A
  • BWEN $3.50
  • P/E Ratio
  • FGEN N/A
  • BWEN N/A
  • Revenue Growth
  • FGEN N/A
  • BWEN N/A
  • 52 Week Low
  • FGEN $4.50
  • BWEN $1.41
  • 52 Week High
  • FGEN $21.94
  • BWEN $3.03
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 50.35
  • BWEN 53.61
  • Support Level
  • FGEN $10.59
  • BWEN $2.17
  • Resistance Level
  • FGEN $11.22
  • BWEN $2.39
  • Average True Range (ATR)
  • FGEN 0.52
  • BWEN 0.19
  • MACD
  • FGEN -0.00
  • BWEN -0.01
  • Stochastic Oscillator
  • FGEN 58.60
  • BWEN 33.87

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: